clinical development strategy

7.16.2014 Clinical Development

All Right, Meow: Patient Recruitment for Animal Health Studies is Serious Business

By Sarah Ray, Research Analyst Patient recruitment isn’t just human subjects. Cutting Edge Information has conducted a number of clinically focused projects, examining an array of industry challenges.  How companies recruit for their clinical...
 

7.7.2014 Clinical Development

Aligning the Goals of a Diverse Risk-Based Management Team

As clinical research monitoring strategy moves toward a risk-based approach, creating a dedicated team to define a risk-based monitoring (RBM) strategy and oversee the management of RBM on a per trial basis is beneficial. Dedicated risk-based management teams are...
 

6.16.2014 Clinical Development

Using Social Media to Improve Oncology Clinical Development and Recruitment

By Natalie DeMasi, Research Analyst Patient recruitment is one of the biggest challenges facing companies involved in oncology clinical development. For example, a recent study by Cutting Edge Information finds that only 43% of surveyed companies...
 

4.23.2014 Clinical Development

[Infographic] Pharmaceutical Advisory Board Recruiting Strategy

By Jacob Presson, Research Analyst When companies begin planning for national-level advisory board meetings, the first step is to delineate a clear objective and a set of goals. These stated aims will serve as useful reference points when recruiting...
 

3.31.2014 Clinical Development

Clinical Trial Management: Risk-Based Monitoring Represents Viable Oversight Solution

By Sarah Ray, Research Analyst With the growth in companies’ pipelines, clinical trial management becomes essential. One aspect of study oversight, monitoring trial risk, has evolved in recent years.  In traditional clinical studies, clinical...
 

1.30.2014 Biomarkers

Can a Video Game Diagnose and Treat Mental Health? Clinical Trials are Underway

By Natalie DeMasi, Research Analyst In today’s age, many people play video games to relieve stress, solve riddles, overcome challenges, conquer opponents and plain-old have fun.  But what if people could play video games as a form of medicine? ...
 

1.6.2014 Biomarkers

Pharma Gets Personal: The Cost of Personalized Medicine

By Victoria Cavicchi, Research Analyst The end of big pharma’s blockbuster era is often in the forefront of the industry’s strategic planning.  Healthcare’s focus has long reflected pharma’s focus on products with far-reaching effects. ...
 

12.23.2013 Clinical Development

Targeting the Alpha 7 Nicotinic Receptor May Be More Difficult Than Companies Originally Anticipated

By Sarah Ray, Research Analyst One of the characteristic symptoms of schizophrenia is patients’ inability to differentiate among important and unimportant stimuli in their environments.  Researchers attribute this symptom to a “P50 Auditory...
 

12.2.2013 Clinical Development

Clinical Teams Should Re-Think Risk-Based Monitoring to Improve Their Bottom Line

By Jennifer Harrell, Research Analyst Often, news surrounding the clinical development process seems pretty grim.  R&D budgets are being slashed, promising new compounds fall short in late-stage trials, patients struggle to find and enroll...
 

11.5.2013 Clinical Development

Expanding Schizophrenic Patients’ Treatment Options: A Look into Companies’ Clinical Pipelines

By Sarah Ray, Research Analyst Back in July, Biopharm Insight noted that a number of companies have drugs with new mechanisms of action (MoAs) that target patients’ negative and cognitive symptoms.  These compounds exist across various stages...